84 related articles for article (PubMed ID: 3572614)
1. Cytoplasmic reactivity with the monoclonal antibody HMFG1 as a marker of cervical glandular atypia.
Brown LJ; Griffin NR; Wells M
J Pathol; 1987 Mar; 151(3):203-8. PubMed ID: 3572614
[TBL] [Abstract][Full Text] [Related]
2. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
3. New monoclonal antibody, 1C5, reactive with human cervical adenocarcinoma of the uterus, with immunodiagnostic potential.
Koizumi M; Uede T; Shijubo N; Kudo R; Hashimoto M; Kikuchi K
Cancer Res; 1988 Nov; 48(22):6565-72. PubMed ID: 3052807
[TBL] [Abstract][Full Text] [Related]
4. Patterns of reactivity with the monoclonal antibodies HMFG1 and HMFG2 in normal endometrium, endometrial hyperplasia and adenocarcinoma.
Morris WP; Griffin NR; Wells M
Histopathology; 1989 Aug; 15(2):179-86. PubMed ID: 2476372
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of p53 and bcl-2 proteins in neoplastic and non-neoplastic endocervical glandular lesions.
McCluggage G; McBride H; Maxwell P; Bharucha H
Int J Gynecol Pathol; 1997 Jan; 16(1):22-7. PubMed ID: 8986528
[TBL] [Abstract][Full Text] [Related]
6. Localization of carcinoembryonic antigen in uterine cervical neoplasia.
Agarwal S; Sharma S
Indian J Med Res; 1990 Dec; 92():452-5. PubMed ID: 2079363
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
Cina SJ; Richardson MS; Austin RM; Kurman RJ
Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
[TBL] [Abstract][Full Text] [Related]
8. Distribution of epithelial-specific antigen in uterine cervix with endocervical glandular dysplasia.
Umezaki K; Sanezumi M; Okada H; Okamura A; Tsubra A; Kanazaki H
Gynecol Oncol; 1997 Sep; 66(3):393-8. PubMed ID: 9299251
[TBL] [Abstract][Full Text] [Related]
9. [Importance of the study of the expression of MIB-1 (Ki-67) for the diagnosis of endocervical glandular lesions].
Leteurtre E; Boman F; Farine MO; Leroy JL; Gosselin B
Ann Pathol; 1998 Jul; 18(3):172-7. PubMed ID: 9706342
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia.
Nishio S; Tsuda H; Fujiyoshi N; Ota S; Ushijima K; Sasajima Y; Kasamatsu T; Kamura T; Matsubara O
Pathol Res Pract; 2009; 205(5):331-7. PubMed ID: 19167836
[TBL] [Abstract][Full Text] [Related]
11. Minimal deviation endocervical adenocarcinoma: clinical and histologic features, immunohistochemical staining for carcinoembryonic antigen, and differentiation from confusing benign lesions.
Michael H; Grawe L; Kraus FT
Int J Gynecol Pathol; 1984; 3(3):261-76. PubMed ID: 6500801
[TBL] [Abstract][Full Text] [Related]
12. Intranuclear cytoplasmic inclusion is a significant diagnostic feature for the differentiation of lobular endocervical glandular hyperplasia from minimal deviation adenocarcinoma of the cervix.
Hashi A; Yuminamochi T; Xu JY; Kondo T; Katoh R; Hoshi K
Diagn Cytopathol; 2008 Aug; 36(8):535-44. PubMed ID: 18618730
[TBL] [Abstract][Full Text] [Related]
13. Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma?: a comparative molecular-genetic and immunohistochemical study.
Kawauchi S; Kusuda T; Liu XP; Suehiro Y; Kaku T; Mikami Y; Takeshita M; Nakao M; Chochi Y; Sasaki K
Am J Surg Pathol; 2008 Dec; 32(12):1807-15. PubMed ID: 18779726
[TBL] [Abstract][Full Text] [Related]
14. Gross features of lobular endocervical glandular hyperplasia in comparison with minimal-deviation adenocarcinoma and stage Ib endocervical-type mucinous adenocarcinoma of the uterine cervix.
Sasajima Y; Mikami Y; Kaku T; Kiyokawa T; Ohishi Y; Hamada T; Sasaki T; Fujita H; Moriya T; Kasamatsu T; Tsuda H
Histopathology; 2008 Oct; 53(4):487-90. PubMed ID: 18631191
[No Abstract] [Full Text] [Related]
15. Lobular endocervical glandular hyperplasia as a presumed precursor of cervical adenocarcinoma independent of human papillomavirus infection.
Nara M; Hashi A; Murata S; Kondo T; Yuminamochi T; Nakazawa K; Katoh R; Hoshi K
Gynecol Oncol; 2007 Aug; 106(2):289-98. PubMed ID: 17540439
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotypic alteration of the stromal component in minimal deviation adenocarcinoma ('adenoma malignum') and endocervical glandular hyperplasia: a study using oestrogen receptor and alpha-smooth muscle actin double immunostaining.
Mikami Y; Kiyokawa T; Moriya T; Sasano H
Histopathology; 2005 Feb; 46(2):130-6. PubMed ID: 15693884
[TBL] [Abstract][Full Text] [Related]
17. Glutathione S-transferase pi is expressed in (pre) neoplastic lesions of the human uterine cervix irrespective of their degree of severity.
Martens JE; Smedts F; ter Harmsel B; Helmerhorst TJ; Ramaekers FC
Anticancer Res; 1997; 17(6D):4305-9. PubMed ID: 9494525
[TBL] [Abstract][Full Text] [Related]
18. [Micro-glandular hyperplasia of the uterine cervix. Histo-cytopathological evaluation, differential diagnosis and review of literature].
Daniele E; Nuara R; Morello V; Nagar C; Tralongo V; Tomasino RM
Pathologica; 1993; 85(1100):607-35. PubMed ID: 8170711
[TBL] [Abstract][Full Text] [Related]
19. Superficial endometriosis of the uterine cervix: a report of 20 cases of a process that may be confused with endocervical glandular dysplasia or adenocarcinoma in situ.
Baker PM; Clement PB; Bell DA; Young RH
Int J Gynecol Pathol; 1999 Jul; 18(3):198-205. PubMed ID: 12090586
[TBL] [Abstract][Full Text] [Related]
20. Expression of human kallikrein 7 (hK7/SCCE) and its inhibitor antileukoprotease (ALP/SLPI) in uterine endocervical glands and in cervical adenocarcinomas.
Tian X; Shigemasa K; Hirata E; Gu L; Uebaba Y; Nagai N; O'Brien TJ; Ohama K
Oncol Rep; 2004 Nov; 12(5):1001-6. PubMed ID: 15492784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
